Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Prostatic Neoplasms
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Retrospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Evaluation of Atherosclerotic Plaques in Prostate Cancer Patients. Study Description: This study measures atherosclerotic plaques in the vessels of prostate cancer patients in contrast-enhanced computed tomography (CECT), then finds correlation between the plaque and clinical biomarkers. These bioma...
Evaluation of Atherosclerotic Plaques in Prostate Cancer Patients. Study Description: This study measures atherosclerotic plaques in the vessels of prostate cancer patients in contrast-enhanced computed tomography (CECT), then finds correlation between the plaque and clinical biomarkers. These biomarkers include laboratory tests, pathologic findings, underlying risk factors, demographic information, and outcomes of the patient. Objectives: Primary objective: Measure atherosclerotic plaques on contrast-enhanced computed tomography (CECT). Secondary objective: Find correlation between plaque measurement and clinical biomarkers of prostate cancer patients. Study Population: Up to 1,000 NIH Clinical Center patients. Description of Sites/Facilities conducting research: NIH Clinical Center Study Duration: 10 years
Tracking Information
- NCT #
- NCT04652973
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ronald M Summers, M.D. National Institutes of Health Clinical Center (CC)
Get Well Soon